Five Alarm Bio's small molecules fight ageing and improve longevity
Live Forever Club - 11-Sep-2024FAB1 compound reduces ageing markers in cells while FAB15 accelerates wound healing
Five Alarm Bio
Company that develops drugs to slow down the ageing process
Anti-aging science has enormous potential. Age-related diseases such as cancer, neurodegenerative diseases are among the leading causes of death and a significant burden on health funding.
Five Alarm Bio is developing a small molecule approach to boost the body’s defence to aging, based on a new understanding of how the chemical damage associated with age accumulates in cells. In addition to a broad range of age-related diseases, Five Alarm Bio sees relevance of its platform for cosmeceuticals.
Founded in 2016 by three experienced entrepreneurs, Five Alarm Bio is based near Cambridge, UK, and is carrying out research at the Babraham Campus.
Five Alarm Bio Executive Team
- Janette Thomas, CEO and Director
- William Bains, CSO and Director
- Peter Tyrer, Lead Research Scientist
- Hannah Mizen, Research Scientist
Five Alarm Bio Directors
- Ann Baker
- Sunil Shah
Five Alarm Bio Advisors
- João Pedro de Magalhães
- David Weinkove
- Andy Morley
- Barry Bentley
Visit website: http://www.fivealarmbio.com/
Details last updated 07-Nov-2020
Mentioned in this Resource
João Pedro de Magalhães
Professor of Molecular Biogerontology at University of Birmingham Institute of Inflammation and Ageing, consultant, futurist, speaker
Five Alarm Bio News
Five Alarm Bio raises seed investment to discover small molecule anti-aging drugs
Cambridge Network - 27-Feb-2023No drug candidates yet, but great to see investors willing to support a broad attack on ageing
Five Alarm Bio to develop drug treatment not to cure ageing but improve healthy lifespan
Cambridge Independent - 04-Nov-2022The company aims at treatments for a range of diseases associated with ageing and disabilities
